The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study

NCT06796504 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsing Remitting Multiple Sclerosis

Interventions

PROCEDURE: Procedure/Surgery: Implant Procedure
DRUG: Disease-Modifying Therapies (DMTs)
DEVICE: Device: Active stimulation
DEVICE: Device: Non-active stimulation

Sponsor

SetPoint Medical Corporation